Methodological Aspects of Acute Toxicity Testing Particularly LD50 Determinations Present use in Development of New Drugs
- 13 March 1983
- journal article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 52 (s2) , 20-30
- https://doi.org/10.1111/j.1600-0773.1983.tb02681.x
Abstract
It is essential to have an adequate understanding of the acute toxic effects of a new drug. It may not be necessary however to blindly follow the full classical median lethal assay on every occasion. The LD50 was developed to obtain the maximum accuracy from a modest experimental size. The objective of the study and the limitations of the assay should not be overlooked however and undue precision should not be sought. Methodological aspects including species and maximum and minimum doses will be discussed. Other methods and approaches to acute toxicity will be recommended with a more broad approach to acute toxicity than lethality alone.Keywords
This publication has 7 references indexed in Scilit:
- Ketotifen overdose: surveillance of the toxicity of a new drug.BMJ, 1981
- National Poisons Information Services: report and comment 1980.BMJ, 1981
- Significance of the LD50-test for the toxicological evaluation of chemical substancesArchives of Toxicology, 1981
- Inadequate information about drug overdosage in manufacturers' data sheets.BMJ, 1980
- The rat toxicity screenPharmacology & Therapeutics, 1979
- The error of determination of toxicityProceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character, 1927